[Fertility preservation in testicular cancer patients].

Heretumoros betegek termékenyítőképességének vizsgálata.

Journal

Magyar onkologia
ISSN: 2060-0399
Titre abrégé: Magy Onkol
Pays: Hungary
ID NLM: 9313833

Informations de publication

Date de publication:
17 Mar 2021
Historique:
received: 05 05 2019
accepted: 14 08 2019
entrez: 17 3 2021
pubmed: 18 3 2021
medline: 20 3 2021
Statut: ppublish

Résumé

Germ cell tumors of the testicle account for 1% of all tumors. Testicular cancer (TC) is the most common malignancy in men aged 15-35 years. Patients with TC have an excellent survival rate but often have not yet attempted to father children, and fertility is one of the main concerns of survivors, therefore it is important to preserve it. The most commonly used method is sperm banking. Retrospective analysis of the Hungarian data showed that in case of testicular cancer spermatogenesis is more impaired in the more advanced disease. No correlation was found among the histological types and the proportion of azoo- and oligozoospermia. The parameters of testicular cancer and non-Hodgkin lymphoma patients were worse compared to the normal population. Sperm cryopreservation prior to initiating life-saving cancer treatment offers men the best chance to father children and should be offered to all men with testicular cancer before chemotherapy, since cytostatic therapy may lead to infertility.

Identifiants

pubmed: 33730117
pii: MagyOnkol.2021.65.1.53

Types de publication

Journal Article

Langues

hun

Sous-ensembles de citation

IM

Pagination

53-57

Auteurs

Tamás Martin (T)

Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com.

Magdolna Dank (M)

Onkológiai Központ, Semmelweis Egyetem, Budapest, Hungary.

Krisztina Biró (K)

Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com.

Zsófia Küronya (Z)

Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com.

Fruzsina Gyergyay (F)

Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com.

Krisztián Nagyiványi (K)

Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com.

Barna Budai (B)

Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com.

Katinka Fűrész (K)

KRIO Intézet, Budapest, Hungary.

Lajos Géczi (L)

Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH